Skip to main content

Table 4 Correlations of 18F-FDG PET/CT parameters and clinical characteristics with the level of VTT

From: Diagnostic performance and prognostic value of preoperative 18F-FDG PET/CT in renal cell carcinoma patients with venous tumor thrombus

Characteristic

Total (n = 59)

Advanced VTT (n = 10)

Early VTT (n = 49)

P value

Clinical parameters

 Age (ys)

54.8 ± 12.8

56.0 ± 15.6

54.6 ± 12.3

0.750a

 Gender

   

0.254c

  Male

42(71.2%)

9(90.0%)

33(67.3%)

 

  Female

17(28.8%)

1(10.0%)

16(32.7%)

 

 Symptoms

   

0.333c

  Presence

50(84.7%)

10(100.0%)

40(81.6%)

 

  Absence

9(15.3%)

0(0.0%)

9(18.4%)

 

 BMI (kg/m2)

25.2 ± 3.6

25.2 ± 2.9

25.2 ± 3.8

0.999a

PET/CT parameters

 Primary tumor SUVmax

6.6(4.3–10.4)

8.7(5.9–10.7)

6.0(4.2–10.8)

0.203b

 VTT SUVmax

3.7(2.5–6.1)

6.5(5.3–8.8)

3.4(2.5–5.4)

0.002b

 Primary tumor size (cm)

8.8 ± 2.5

9.4 ± 3.3

8.7 ± 2.4

0.450a

  1. Continuous variables (age, BMI, primary tumor SUVmax, VTT SUVmax and primary tumor size) are expressed as the median (first quartile-third quartile, Q1-Q3) or mean value ± SD. Categoric variables (gender, symptoms) were expressed as numbers (percentages). P value < 0.05 was highlighted using bold font
  2. Abbreviations: VTT venous tumor thrombus, BMI body mass index, SUVmax maximum standardized uptake value
  3. aStudent’s t test
  4. bMann-Whitney U test
  5. cFisher’s exact test